Structure

Physi-Chem Properties

Molecular Weight:  424.3
Volume:  465.887
LogP:  5.632
LogD:  4.655
LogS:  -6.388
# Rotatable Bonds:  0
TPSA:  51.21
# H-Bond Aceptor:  3
# H-Bond Donor:  0
# Rings:  5
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.356
Synthetic Accessibility Score:  4.945
Fsp3:  0.821
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.096
MDCK Permeability:  1.6091811630758457e-05
Pgp-inhibitor:  0.941
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.012
20% Bioavailability (F20%):  0.019
30% Bioavailability (F30%):  0.943

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.218
Plasma Protein Binding (PPB):  94.69322204589844%
Volume Distribution (VD):  0.6
Pgp-substrate:  4.235454082489014%

ADMET: Metabolism

CYP1A2-inhibitor:  0.024
CYP1A2-substrate:  0.595
CYP2C19-inhibitor:  0.225
CYP2C19-substrate:  0.941
CYP2C9-inhibitor:  0.363
CYP2C9-substrate:  0.175
CYP2D6-inhibitor:  0.041
CYP2D6-substrate:  0.568
CYP3A4-inhibitor:  0.942
CYP3A4-substrate:  0.82

ADMET: Excretion

Clearance (CL):  12.625
Half-life (T1/2):  0.073

ADMET: Toxicity

hERG Blockers:  0.015
Human Hepatotoxicity (H-HT):  0.275
Drug-inuced Liver Injury (DILI):  0.188
AMES Toxicity:  0.016
Rat Oral Acute Toxicity:  0.69
Maximum Recommended Daily Dose:  0.826
Skin Sensitization:  0.079
Carcinogencity:  0.278
Eye Corrosion:  0.004
Eye Irritation:  0.012
Respiratory Toxicity:  0.944

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC53733

Natural Product ID:  NPC53733
Common Name*:   Remangilone C
IUPAC Name:   (4aR,6aR,6bS,8aS,12aR,14aR,14bR)-3-hydroxy-4,6a,6b,11,11,14b-hexamethyl-1,4a,5,6,7,8a,9,10,12,12a,14,14a-dodecahydropicene-2,8-dione
Synonyms:   Remangilone C
Standard InCHIKey:  DDLHISCCNYFWOT-PSSYVLGHSA-N
Standard InCHI:  InChI=1S/C28H40O3/c1-16-19-10-12-27(5)23(26(19,4)14-22(30)24(16)31)8-7-20-18-13-25(2,3)11-9-17(18)21(29)15-28(20,27)6/h7,17-19,23,31H,8-15H2,1-6H3/t17-,18+,19-,23+,26-,27+,28+/m0/s1
SMILES:  CC1=C(C(=O)C[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2CC=C2[C@@H]3CC(C)(C)CC[C@@H]3C(=O)C[C@@]12C)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL454824
PubChem CID:   44558996
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO12587 Physena madagascariensis Species Physenaceae Eukaryota n.a. n.a. n.a. PMID[10096861]
NPO12587 Physena madagascariensis Species Physenaceae Eukaryota n.a. n.a. n.a. PMID[10978202]
NPO12587 Physena madagascariensis Species Physenaceae Eukaryota n.a. leaf n.a. PMID[10978202]
NPO12587 Physena madagascariensis Species Physenaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT400 Cell Line MDA-MB-435 Homo sapiens IC50 = 2000.0 nM PMID[533545]
NPT82 Cell Line MDA-MB-231 Homo sapiens IC50 = 1600.0 nM PMID[533545]
NPT27 Others Unspecified IC50 = 51600.0 nM PMID[533545]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC53733 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9359 High Similarity NPC18955
0.9114 High Similarity NPC108955
0.9048 High Similarity NPC65615
0.9048 High Similarity NPC112454
0.9048 High Similarity NPC68148
0.9024 High Similarity NPC469993
0.9024 High Similarity NPC474537
0.9 High Similarity NPC471898
0.9 High Similarity NPC55869
0.8953 High Similarity NPC263780
0.8902 High Similarity NPC96095
0.8875 High Similarity NPC287063
0.8851 High Similarity NPC23170
0.8846 High Similarity NPC92080
0.8837 High Similarity NPC470036
0.8837 High Similarity NPC174167
0.8765 High Similarity NPC475863
0.8765 High Similarity NPC225515
0.8765 High Similarity NPC162632
0.8765 High Similarity NPC274050
0.8765 High Similarity NPC263272
0.8765 High Similarity NPC3915
0.8765 High Similarity NPC267691
0.875 High Similarity NPC147232
0.8736 High Similarity NPC211230
0.8675 High Similarity NPC53385
0.8659 High Similarity NPC310989
0.8659 High Similarity NPC69101
0.8659 High Similarity NPC251779
0.8659 High Similarity NPC103486
0.8642 High Similarity NPC2482
0.8636 High Similarity NPC474882
0.8625 High Similarity NPC476808
0.8625 High Similarity NPC189485
0.8625 High Similarity NPC30321
0.8571 High Similarity NPC132228
0.8571 High Similarity NPC33881
0.8571 High Similarity NPC6185
0.8571 High Similarity NPC8518
0.8571 High Similarity NPC241512
0.8571 High Similarity NPC263997
0.8554 High Similarity NPC70834
0.8554 High Similarity NPC309309
0.8554 High Similarity NPC291999
0.8554 High Similarity NPC105803
0.8539 High Similarity NPC777
0.8537 High Similarity NPC278459
0.8537 High Similarity NPC470034
0.8537 High Similarity NPC473217
0.8519 High Similarity NPC192329
0.8519 High Similarity NPC231431
0.8519 High Similarity NPC27817
0.8519 High Similarity NPC16394
0.85 High Similarity NPC471897
0.85 High Similarity NPC107039
0.85 High Similarity NPC165711
0.85 High Similarity NPC471899
0.8452 Intermediate Similarity NPC144258
0.8452 Intermediate Similarity NPC237712
0.8452 Intermediate Similarity NPC180834
0.8427 Intermediate Similarity NPC474328
0.8427 Intermediate Similarity NPC160413
0.8415 Intermediate Similarity NPC476809
0.8415 Intermediate Similarity NPC37038
0.8395 Intermediate Similarity NPC471409
0.8395 Intermediate Similarity NPC280654
0.8395 Intermediate Similarity NPC110094
0.8395 Intermediate Similarity NPC275494
0.8395 Intermediate Similarity NPC260385
0.8375 Intermediate Similarity NPC1254
0.8375 Intermediate Similarity NPC112680
0.8375 Intermediate Similarity NPC89294
0.8372 Intermediate Similarity NPC93778
0.8353 Intermediate Similarity NPC133954
0.8353 Intermediate Similarity NPC133652
0.8353 Intermediate Similarity NPC474680
0.8353 Intermediate Similarity NPC274724
0.8333 Intermediate Similarity NPC190035
0.8333 Intermediate Similarity NPC307258
0.8313 Intermediate Similarity NPC44963
0.8313 Intermediate Similarity NPC474085
0.8313 Intermediate Similarity NPC121984
0.8313 Intermediate Similarity NPC472684
0.8313 Intermediate Similarity NPC142244
0.8295 Intermediate Similarity NPC252737
0.8295 Intermediate Similarity NPC46441
0.8293 Intermediate Similarity NPC215843
0.8293 Intermediate Similarity NPC199595
0.8276 Intermediate Similarity NPC472802
0.8276 Intermediate Similarity NPC230387
0.8256 Intermediate Similarity NPC327115
0.8256 Intermediate Similarity NPC158393
0.8256 Intermediate Similarity NPC475862
0.8256 Intermediate Similarity NPC94666
0.8256 Intermediate Similarity NPC74363
0.8256 Intermediate Similarity NPC213412
0.8235 Intermediate Similarity NPC473246
0.8235 Intermediate Similarity NPC214043
0.8235 Intermediate Similarity NPC85774
0.8214 Intermediate Similarity NPC48362
0.8214 Intermediate Similarity NPC193347
0.8214 Intermediate Similarity NPC320514
0.8202 Intermediate Similarity NPC158030
0.8202 Intermediate Similarity NPC65120
0.8202 Intermediate Similarity NPC4036
0.8202 Intermediate Similarity NPC145067
0.8202 Intermediate Similarity NPC233455
0.8202 Intermediate Similarity NPC474525
0.8193 Intermediate Similarity NPC267517
0.8193 Intermediate Similarity NPC104545
0.8182 Intermediate Similarity NPC184663
0.8182 Intermediate Similarity NPC477973
0.8171 Intermediate Similarity NPC74410
0.8161 Intermediate Similarity NPC173089
0.8161 Intermediate Similarity NPC158141
0.8161 Intermediate Similarity NPC73064
0.8161 Intermediate Similarity NPC71507
0.8161 Intermediate Similarity NPC470523
0.8148 Intermediate Similarity NPC110725
0.8148 Intermediate Similarity NPC292589
0.8148 Intermediate Similarity NPC180886
0.814 Intermediate Similarity NPC469948
0.814 Intermediate Similarity NPC33663
0.814 Intermediate Similarity NPC29447
0.8118 Intermediate Similarity NPC200752
0.8111 Intermediate Similarity NPC295643
0.8111 Intermediate Similarity NPC272075
0.8111 Intermediate Similarity NPC214756
0.8095 Intermediate Similarity NPC477372
0.8095 Intermediate Similarity NPC147066
0.8095 Intermediate Similarity NPC189237
0.8095 Intermediate Similarity NPC201912
0.8095 Intermediate Similarity NPC116797
0.8095 Intermediate Similarity NPC38350
0.8095 Intermediate Similarity NPC221647
0.809 Intermediate Similarity NPC85173
0.8077 Intermediate Similarity NPC286814
0.8068 Intermediate Similarity NPC474474
0.8068 Intermediate Similarity NPC470524
0.8068 Intermediate Similarity NPC206060
0.8068 Intermediate Similarity NPC1753
0.8068 Intermediate Similarity NPC474511
0.8049 Intermediate Similarity NPC266193
0.8049 Intermediate Similarity NPC472300
0.8049 Intermediate Similarity NPC476811
0.8049 Intermediate Similarity NPC257666
0.8046 Intermediate Similarity NPC235341
0.8046 Intermediate Similarity NPC51014
0.8046 Intermediate Similarity NPC477579
0.8046 Intermediate Similarity NPC474778
0.8046 Intermediate Similarity NPC95594
0.8046 Intermediate Similarity NPC474733
0.8046 Intermediate Similarity NPC145879
0.8046 Intermediate Similarity NPC474732
0.8046 Intermediate Similarity NPC31564
0.8043 Intermediate Similarity NPC473158
0.8025 Intermediate Similarity NPC279666
0.8025 Intermediate Similarity NPC192540
0.8025 Intermediate Similarity NPC175079
0.8023 Intermediate Similarity NPC329043
0.8023 Intermediate Similarity NPC161423
0.8023 Intermediate Similarity NPC321187
0.8023 Intermediate Similarity NPC476412
0.8023 Intermediate Similarity NPC156981
0.8023 Intermediate Similarity NPC58841
0.8023 Intermediate Similarity NPC227064
0.8022 Intermediate Similarity NPC74751
0.8 Intermediate Similarity NPC260956
0.8 Intermediate Similarity NPC238991
0.8 Intermediate Similarity NPC163236
0.8 Intermediate Similarity NPC302661
0.8 Intermediate Similarity NPC272746
0.8 Intermediate Similarity NPC230064
0.7978 Intermediate Similarity NPC69627
0.7978 Intermediate Similarity NPC310010
0.7978 Intermediate Similarity NPC474700
0.7978 Intermediate Similarity NPC326627
0.7978 Intermediate Similarity NPC281524
0.7976 Intermediate Similarity NPC26139
0.7976 Intermediate Similarity NPC477057
0.7976 Intermediate Similarity NPC469637
0.7976 Intermediate Similarity NPC472478
0.7955 Intermediate Similarity NPC102683
0.7955 Intermediate Similarity NPC51700
0.7955 Intermediate Similarity NPC171203
0.7955 Intermediate Similarity NPC130577
0.7955 Intermediate Similarity NPC18064
0.7955 Intermediate Similarity NPC58063
0.7955 Intermediate Similarity NPC88716
0.7955 Intermediate Similarity NPC98442
0.7955 Intermediate Similarity NPC242468
0.7955 Intermediate Similarity NPC307426
0.7955 Intermediate Similarity NPC475740
0.7955 Intermediate Similarity NPC293564
0.7955 Intermediate Similarity NPC68160
0.7955 Intermediate Similarity NPC142415
0.7955 Intermediate Similarity NPC136948
0.7949 Intermediate Similarity NPC39157
0.7949 Intermediate Similarity NPC82477
0.7949 Intermediate Similarity NPC142754

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC53733 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9048 High Similarity NPD7285 Clinical (unspecified phase)
0.8875 High Similarity NPD4695 Discontinued
0.8625 High Similarity NPD3617 Approved
0.8571 High Similarity NPD5329 Approved
0.8452 Intermediate Similarity NPD4197 Approved
0.8256 Intermediate Similarity NPD5280 Approved
0.8256 Intermediate Similarity NPD5690 Phase 2
0.8256 Intermediate Similarity NPD4694 Approved
0.8214 Intermediate Similarity NPD4223 Phase 3
0.8214 Intermediate Similarity NPD4221 Approved
0.8202 Intermediate Similarity NPD7515 Phase 2
0.8046 Intermediate Similarity NPD5279 Phase 3
0.8023 Intermediate Similarity NPD3133 Approved
0.8023 Intermediate Similarity NPD3665 Phase 1
0.8023 Intermediate Similarity NPD3666 Approved
0.8022 Intermediate Similarity NPD7748 Approved
0.7978 Intermediate Similarity NPD4753 Phase 2
0.7849 Intermediate Similarity NPD7614 Phase 1
0.7841 Intermediate Similarity NPD4688 Approved
0.7841 Intermediate Similarity NPD4138 Approved
0.7841 Intermediate Similarity NPD4689 Approved
0.7841 Intermediate Similarity NPD4693 Phase 3
0.7841 Intermediate Similarity NPD5205 Approved
0.7841 Intermediate Similarity NPD4690 Approved
0.7841 Intermediate Similarity NPD4623 Approved
0.7841 Intermediate Similarity NPD3618 Phase 1
0.7841 Intermediate Similarity NPD4519 Discontinued
0.7816 Intermediate Similarity NPD4786 Approved
0.7791 Intermediate Similarity NPD3667 Approved
0.7778 Intermediate Similarity NPD5328 Approved
0.7766 Intermediate Similarity NPD7902 Approved
0.7667 Intermediate Similarity NPD6672 Approved
0.7667 Intermediate Similarity NPD5737 Approved
0.7667 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.764 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.7625 Intermediate Similarity NPD4137 Phase 3
0.7609 Intermediate Similarity NPD6079 Approved
0.7582 Intermediate Similarity NPD6673 Approved
0.7582 Intermediate Similarity NPD6080 Approved
0.7582 Intermediate Similarity NPD6904 Approved
0.7579 Intermediate Similarity NPD6084 Phase 2
0.7579 Intermediate Similarity NPD6083 Phase 2
0.7553 Intermediate Similarity NPD5210 Approved
0.7553 Intermediate Similarity NPD5695 Phase 3
0.7553 Intermediate Similarity NPD4629 Approved
0.7531 Intermediate Similarity NPD4691 Approved
0.7531 Intermediate Similarity NPD4747 Approved
0.7527 Intermediate Similarity NPD5133 Approved
0.75 Intermediate Similarity NPD4788 Approved
0.7474 Intermediate Similarity NPD4697 Phase 3
0.7474 Intermediate Similarity NPD5221 Approved
0.7474 Intermediate Similarity NPD5222 Approved
0.7474 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.7471 Intermediate Similarity NPD8028 Phase 2
0.747 Intermediate Similarity NPD5733 Approved
0.7447 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7447 Intermediate Similarity NPD7900 Approved
0.7444 Intermediate Similarity NPD7334 Approved
0.7444 Intermediate Similarity NPD7146 Approved
0.7444 Intermediate Similarity NPD7521 Approved
0.7444 Intermediate Similarity NPD6684 Approved
0.7444 Intermediate Similarity NPD5330 Approved
0.7444 Intermediate Similarity NPD6409 Approved
0.7444 Intermediate Similarity NPD6098 Approved
0.7442 Intermediate Similarity NPD4195 Approved
0.7419 Intermediate Similarity NPD5284 Approved
0.7419 Intermediate Similarity NPD6050 Approved
0.7419 Intermediate Similarity NPD5281 Approved
0.7396 Intermediate Similarity NPD4755 Approved
0.7396 Intermediate Similarity NPD5173 Approved
0.7363 Intermediate Similarity NPD3573 Approved
0.734 Intermediate Similarity NPD4202 Approved
0.732 Intermediate Similarity NPD5696 Approved
0.7312 Intermediate Similarity NPD4096 Approved
0.7312 Intermediate Similarity NPD5692 Phase 3
0.7292 Intermediate Similarity NPD7732 Phase 3
0.7283 Intermediate Similarity NPD6903 Approved
0.7273 Intermediate Similarity NPD4139 Approved
0.7273 Intermediate Similarity NPD4692 Approved
0.7262 Intermediate Similarity NPD4058 Approved
0.7262 Intermediate Similarity NPD4687 Approved
0.725 Intermediate Similarity NPD7331 Phase 2
0.7245 Intermediate Similarity NPD5285 Approved
0.7245 Intermediate Similarity NPD5286 Approved
0.7245 Intermediate Similarity NPD4700 Approved
0.7245 Intermediate Similarity NPD4696 Approved
0.7241 Intermediate Similarity NPD7645 Phase 2
0.7234 Intermediate Similarity NPD5693 Phase 1
0.7234 Intermediate Similarity NPD5694 Approved
0.7229 Intermediate Similarity NPD5276 Approved
0.7222 Intermediate Similarity NPD3668 Phase 3
0.7172 Intermediate Similarity NPD5223 Approved
0.7158 Intermediate Similarity NPD6399 Phase 3
0.7125 Intermediate Similarity NPD7341 Phase 2
0.71 Intermediate Similarity NPD5225 Approved
0.71 Intermediate Similarity NPD5226 Approved
0.71 Intermediate Similarity NPD5091 Approved
0.71 Intermediate Similarity NPD4633 Approved
0.71 Intermediate Similarity NPD5211 Phase 2
0.71 Intermediate Similarity NPD5224 Approved
0.7097 Intermediate Similarity NPD5208 Approved
0.7097 Intermediate Similarity NPD4518 Approved
0.7073 Intermediate Similarity NPD3621 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD6675 Approved
0.7059 Intermediate Similarity NPD7128 Approved
0.7059 Intermediate Similarity NPD5739 Approved
0.7059 Intermediate Similarity NPD6402 Approved
0.703 Intermediate Similarity NPD5175 Approved
0.703 Intermediate Similarity NPD4754 Approved
0.703 Intermediate Similarity NPD5174 Approved
0.7024 Intermediate Similarity NPD4243 Approved
0.6966 Remote Similarity NPD8259 Clinical (unspecified phase)
0.6961 Remote Similarity NPD5141 Approved
0.6957 Remote Similarity NPD7520 Clinical (unspecified phase)
0.6947 Remote Similarity NPD5207 Approved
0.6923 Remote Similarity NPD6881 Approved
0.6923 Remote Similarity NPD6899 Approved
0.6923 Remote Similarity NPD7320 Approved
0.6905 Remote Similarity NPD4789 Approved
0.6893 Remote Similarity NPD4768 Approved
0.6893 Remote Similarity NPD4767 Approved
0.6875 Remote Similarity NPD2664 Clinical (unspecified phase)
0.686 Remote Similarity NPD4785 Approved
0.686 Remote Similarity NPD4784 Approved
0.6857 Remote Similarity NPD6373 Approved
0.6857 Remote Similarity NPD6372 Approved
0.6837 Remote Similarity NPD5654 Approved
0.6837 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6827 Remote Similarity NPD6412 Phase 2
0.6827 Remote Similarity NPD5701 Approved
0.6827 Remote Similarity NPD5697 Approved
0.6792 Remote Similarity NPD7102 Approved
0.6792 Remote Similarity NPD6883 Approved
0.6792 Remote Similarity NPD7290 Approved
0.6782 Remote Similarity NPD7339 Approved
0.6782 Remote Similarity NPD6942 Approved
0.6762 Remote Similarity NPD5168 Approved
0.6762 Remote Similarity NPD4730 Approved
0.6762 Remote Similarity NPD6011 Approved
0.6762 Remote Similarity NPD5128 Approved
0.6762 Remote Similarity NPD4729 Approved
0.6735 Remote Similarity NPD6001 Approved
0.6733 Remote Similarity NPD6404 Discontinued
0.6729 Remote Similarity NPD6869 Approved
0.6729 Remote Similarity NPD6847 Approved
0.6729 Remote Similarity NPD6617 Approved
0.6729 Remote Similarity NPD6649 Approved
0.6729 Remote Similarity NPD8130 Phase 1
0.6729 Remote Similarity NPD6401 Clinical (unspecified phase)
0.6729 Remote Similarity NPD6650 Approved
0.6705 Remote Similarity NPD3701 Clinical (unspecified phase)
0.67 Remote Similarity NPD5959 Approved
0.6698 Remote Similarity NPD6013 Approved
0.6698 Remote Similarity NPD6014 Approved
0.6698 Remote Similarity NPD6012 Approved
0.6667 Remote Similarity NPD5361 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5360 Phase 3
0.6667 Remote Similarity NPD8297 Approved
0.6667 Remote Similarity NPD6882 Approved
0.6636 Remote Similarity NPD5135 Approved
0.6636 Remote Similarity NPD5247 Approved
0.6636 Remote Similarity NPD5250 Approved
0.6636 Remote Similarity NPD4634 Approved
0.6636 Remote Similarity NPD5248 Approved
0.6636 Remote Similarity NPD5169 Approved
0.6636 Remote Similarity NPD5251 Approved
0.6636 Remote Similarity NPD5134 Clinical (unspecified phase)
0.6636 Remote Similarity NPD5249 Phase 3
0.6634 Remote Similarity NPD7638 Approved
0.663 Remote Similarity NPD4752 Clinical (unspecified phase)
0.6627 Remote Similarity NPD4224 Phase 2
0.6593 Remote Similarity NPD7525 Registered
0.6591 Remote Similarity NPD4190 Phase 3
0.6591 Remote Similarity NPD5275 Approved
0.6582 Remote Similarity NPD287 Approved
0.6574 Remote Similarity NPD5215 Approved
0.6574 Remote Similarity NPD5127 Approved
0.6574 Remote Similarity NPD5217 Approved
0.6574 Remote Similarity NPD5216 Approved
0.6569 Remote Similarity NPD7639 Approved
0.6569 Remote Similarity NPD7640 Approved
0.6559 Remote Similarity NPD3527 Clinical (unspecified phase)
0.6531 Remote Similarity NPD8035 Phase 2
0.6531 Remote Similarity NPD8034 Phase 2
0.6531 Remote Similarity NPD6411 Approved
0.6522 Remote Similarity NPD8328 Phase 3
0.6512 Remote Similarity NPD4245 Approved
0.6512 Remote Similarity NPD4244 Approved
0.6509 Remote Similarity NPD6614 Approved
0.6486 Remote Similarity NPD6868 Approved
0.6476 Remote Similarity NPD7812 Clinical (unspecified phase)
0.6455 Remote Similarity NPD4632 Approved
0.6437 Remote Similarity NPD4809 Clinical (unspecified phase)
0.6437 Remote Similarity NPD6081 Approved
0.6437 Remote Similarity NPD4808 Clinical (unspecified phase)
0.6429 Remote Similarity NPD6108 Clinical (unspecified phase)
0.6421 Remote Similarity NPD1696 Phase 3
0.64 Remote Similarity NPD5282 Discontinued
0.6396 Remote Similarity NPD5167 Approved
0.6395 Remote Similarity NPD3699 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data